Rodney Dawson Selected Research

Ethambutol (Myambutol)

1/2020	Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
12/2019	Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.
1/2018	Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
1/2018	A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses.
1/2017	High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
5/2015	Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rodney Dawson Research Topics

Disease

35	Tuberculosis (Tuberculoses) 10/2021 - 08/2008
18	Pulmonary Tuberculosis 10/2021 - 08/2010
6	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 06/2012
3	HIV Infections (HIV Infection) 10/2021 - 08/2008
2	Extensively Drug-Resistant Tuberculosis 01/2021 - 07/2013
2	Infections 01/2020 - 08/2008
2	Body Weight (Weight, Body) 05/2015 - 06/2012
1	Granuloma 10/2021
1	Pleural Tuberculosis 10/2021
1	Extrapulmonary Tuberculosis 10/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Heart Failure 01/2020
1	Emphysema 01/2020
1	Coinfection 01/2017
1	Hematuria 01/2017
1	Ventricular Tachycardia 05/2015
1	Reinfection 12/2013
1	Pericarditis 11/2011
1	Pleural Effusion (Pleural Effusions) 01/2009

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 10/2021 - 08/2010
17	Rifampin (Rifampicin)FDA LinkGeneric 10/2021 - 05/2011
8	pretomanidIBA 02/2021 - 08/2010
8	Pyrazinamide FDA LinkGeneric 01/2021 - 07/2013
8	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 05/2015
6	Ethambutol (Myambutol)FDA LinkGeneric 01/2020 - 05/2015
5	Moxifloxacin (Avelox)FDA Link 12/2019 - 07/2013
4	bedaquiline (R207910)IBA 01/2021 - 05/2013
3	Linezolid (Zyvox)FDA Link 01/2021 - 01/2020
2	RifamycinsIBA 01/2021 - 01/2019
2	Clofazimine (Lamprene)FDA Link 01/2021 - 04/2015
2	Tuberculin (PPD)IBA 01/2020 - 08/2008
2	Adenosine DeaminaseIBA 01/2014 - 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	Rifabutin (Ansamycin)FDA Link 01/2021
1	Antitubercular AgentsIBA 01/2021
1	APTIBA 01/2021
1	NitroimidazolesIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	thiamine triphosphorate (TTP)IBA 12/2019
1	rifapentine (Priftin)FDA Link 01/2019
1	EnzymesIBA 01/2018
1	AcidsIBA 01/2017
1	VaccinesIBA 01/2017
1	Tuberculosis VaccinesIBA 01/2017
1	AERAS-402IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 05/2015
1	AerosolsIBA 01/2014
1	PNU-100480IBA 01/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	dimemorfan (AT 17)IBA 12/2013
1	Biological ProductsIBA 12/2013
1	Biomarkers (Surrogate Marker)IBA 08/2013
1	DNA (Deoxyribonucleic Acid)IBA 08/2013
1	CytokinesIBA 01/2013
1	Interleukin-22 (IL-22)IBA 11/2011
1	Interleukin-17 (Interleukin 17)IBA 11/2011
1	lipoarabinomannan (LAM)IBA 01/2009
1	AntigensIBA 01/2009
1	Nucleic AcidsIBA 01/2009

Therapy/Procedure

10	Therapeutics 01/2020 - 08/2010
3	Aftercare (After-Treatment) 01/2020 - 08/2013
2	Duration of Therapy 01/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 11/2018 - 01/2018
1	Secondary Prevention 01/2021
1	Art Therapy 04/2017